Clinical Trials Browser

Has results × Celecoxib × Gastrointestinal × Clear all

NCT00151476 2024-09-04

Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients

68 enrolled 22 charts

Gastrointestinal

Adenomatous Polyposis Coli

NCT01545141 2023-10-27

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Phase 1/2 Terminated

15 enrolled 9 charts

Gastrointestinal

Neoplasm Metastasis, Recurrence, Colorectal Neoplasms

NCT00503035 2023-02-13

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

Phase 2 Completed

51 enrolled 10 charts

Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT01150045 2022-03-22

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Phase 3 Unknown

2,527 enrolled 14 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT03403634 2022-03-02

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

Phase 2 Completed

19 enrolled 15 charts

Gastrointestinal

Colorectal Neoplasms

NCT00585312 2021-02-21

CHIP

Phase 3 Terminated

106 enrolled 10 charts

Gastrointestinal

Adenomatous Polyposis Coli

NCT00033371 2020-09-29

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

Phase 2 Completed

205 enrolled 16 charts

Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT01284504 2018-03-16

Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer

Phase NA Terminated

1 enrolled 3 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT01729923 2018-01-16

ADAPT

Phase 2 Terminated

27 enrolled 10 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00582660 2017-06-15

UAB0040

Phase 2 Completed

40 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms

NCT00198081 2016-02-29

Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)

Phase 2 Terminated

8 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00305643 2015-12-24

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Phase 3 Terminated

11 enrolled 7 charts

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pain, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome, Drug-Related Side Effects and Adverse Reactions

NCT00250835 2015-09-01

Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer

Phase 2 Terminated

38 enrolled 11 charts

Gastrointestinal

Neoplasms, Rectal Neoplasms

NCT00466505 2012-12-19

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

Phase 2 Completed

17 enrolled 15 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms